Source: Eur Respir J 2003 Dec 01;22(6):876-882
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Ioanas M., Cavalcanti M., Ferrer M., Valencia M., Agusti C., Puig de la Bellac... J., Torres A.. Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines. Eur Respir J 2003 Dec 01;22(6):876-882

Member's Comments

No comment yet.

Related content which might interest you: Validation of treatment adequacy of current guidelines for hospital-acquired pneumonia Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU Year: 2003 Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome Source: Eur Respir J 2008; 32: 892-901 Year: 2008 Guideline-concordant therapy and outcomes in healthcare-associated pneumonia Source: Eur Respir J 2011; 38: 878-887 Year: 2011 Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia Source: Eur Respir J 2011; 37: 1332-1339 Year: 2011 Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis Source: Eur Respir J 2011; 37: 858-864 Year: 2011 Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia Source: ERJ Open Res, 4 (2) 00028-2018; 10.1183/23120541.00028-2018 Year: 2018 Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia Source: Guideline 2018 Year: 2019 Impact of guidelines on HAP and VAP outcomes Source: Eur Respir Mon 2011; 53: 66-73 Year: 2011 Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens Source: Eur Respir J 2002; 20: 432-439 Year: 2002 The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Guideline 2017 Year: 2017 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017 Year: 2017 Relevance of correct antibiotic choice in community-acquired pneumonia (CAP) Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 From international guidelines to local guidelines for nosocomial pneumonia: what is missing? Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution Year: 2019 Verifying the antibiotic selection algorithm in the new Japanese pneumonia guidelines - Is algorithm-discordant treatment associated with increased mortality of healthcare-associated pneumonia? Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 Adherence to guidelines and clinical stability in community-acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 241s Year: 2004 Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia Source: Eur Respir J 2007; 29: 751-756 Year: 2007 Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005 Can CAP guideline adherence improve patient outcome in internal medicine departments? Source: Eur Respir J 2008; 32: 902-910 Year: 2008 CAP and HAP guidelines: treatment indications and more Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006